BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Marchioni RM, Lichtenstein GR. Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review. World J Gastroenterol 2013; 19(17): 2591-2602 [PMID: 23674866 DOI: 10.3748/wjg.v19.i17.2591]
URL: https://www.wjgnet.com/2220-3214/full/v19/i17/2591.htm
Number Citing Articles
1
Wendy J. Carman, Neil A. Accortt, Mary S. Anthony, Janet Iles, Cheryl Enger. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept usePharmacoepidemiology and Drug Safety 2017; 26(9): 1109 doi: 10.1002/pds.4261
2
J.W. Wieringa, C.J. van der Woude. Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel diseaseBest Practice & Research Clinical Gastroenterology 2020; : 101665 doi: 10.1016/j.bpg.2019.101665
3
Sarah Madeline Brown, Khadija Aljefri, Rachel Waas, Philip Hampton. Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluidJournal of Dermatological Treatment 2019; 30(1): 2 doi: 10.1080/09546634.2016.1202402
4
Roxana-Georgiana Juverdeanu, Cayetano Alegre. Fármacos que inhiben el factor de necrosis tumoral α y embarazoMedicina Clínica 2014; 143(5): 236 doi: 10.1016/j.medcli.2013.10.028
5
Tamara Lund, Simon Francis Thomsen. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient seriesDermatologic Therapy 2017; 30(3): e12454 doi: 10.1111/dth.12454
6
Rena H Cao, Michael C Grimm. Pregnancy and medications in inflammatory bowel diseaseObstetric Medicine 2021; 14(1): 4 doi: 10.1177/1753495X20919214
7
Ariela Hoxha, Antonia Calligaro, Emma Di Poi, Susanna Peccatori, Maria Favaro, Teresa Del Ross, Roberta Ramonda, Chiara Grava, Bernd Raffeiner, Paola Ravagni, Salvatore De Vita, Amelia Ruffatti. Devenir de la grossesse et de l’enfant après traitement par anti-TNF alpha : étude prospective multicentriqueRevue du Rhumatisme 2018; 85(1): 49 doi: 10.1016/j.rhum.2017.07.009
8
Natalia Mena-Vazquez, Sara Manrique-Arija, Antonio Fernandez-Nebro. Safety of biologic therapies during pregnancy in women with rheumatic diseaseWorld Journal of Rheumatology 2015; 5(2): 82-89 doi: 10.5499/wjr.v5.i2.82
9
Juejing Ling, Gideon Koren. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancyExpert Review of Vaccines 2016; 15(2): 239 doi: 10.1586/14760584.2016.1115351
10
Charlene Porter, Sylvia Armstrong-Fisher, Tim Kopotsha, Bryan Smith, Terry Baker, Lara Kevorkian, Andrew Nesbitt. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transferJournal of Reproductive Immunology 2016; 116: 7 doi: 10.1016/j.jri.2016.04.284
11
Akarsu Sevgi. Interaction of psoriasis and pregnancy: Maternal and fetal outcomesArchives of Anatomy and Physiology 2020; 5(1): 001 doi: 10.17352/aap.000013
12
M. V. Shapina, I. L. Khalif, V. A. Nanaeva. CERTOLIZUMAB PEGOL IN CHOHN'S DISEASE (review)Koloproktologia 2016; (3): 102 doi: 10.33878/2073-7556-2016-0-3-102-108
13
I. Belinchón, M. Velasco, M. Ara-Martín, S. Armesto Alonso, O. Baniandrés Rodríguez, L. Ferrándiz Pulido, M. García-Bustinduy, J.A. Martínez-López, N. Martínez Sánchez, A. Pérez Ferriols, E. Pérez Pascual, R. Rivera Díaz, R. Ruiz-Villaverde, R. Taberner Ferrer, A. Vicente Villa, J.M. Carrascosa. Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus StatementActas Dermo-Sifiliográficas (English Edition) 2021; 112(3): 225 doi: 10.1016/j.adengl.2020.10.031
14
Jun Zhang, Ying Cui, Yinfang Wu, Huiju Wang, Jinjing Ke. Prediction and identification of B-cell epitopes for tumor necrosis factor-αMolecular Medicine Reports 2017; 16(3): 3439 doi: 10.3892/mmr.2017.7007
15
David James, Philip J. Steer, Carl P. Weiner, Bernard Gonik, Stephen C, Robson. High-Risk Pregnancy2018;  doi: 10.1017/9781108349185
16
Ronald F. van Vollenhoven. Biologics for the Treatment of Rheumatoid Arthritis2016; : 109 doi: 10.1007/978-3-319-13108-5_9
17
Renata Baronaite Hansen, Arthur Kavanaugh. Certolizumab pegol for the treatment of psoriatic arthritisExpert Review of Clinical Immunology 2015; 11(3): 307 doi: 10.1586/1744666X.2015.1009897
18
Hye Won Lee, Won Ho Kim, Jae Hee Cheon. The Medical Treatments of Intestinal Behçet's Disease: An UpdateIntestinal Research 2013; 11(3): 155 doi: 10.5217/ir.2013.11.3.155
19
Corinna Weber-Schöndorfer. Drugs During Pregnancy and Lactation2015; : 341 doi: 10.1016/B978-0-12-408078-2.00013-5
20
Karen Priscilla Tezotto Pendeloski, Erika Ono, Maria Regina Torloni, Rosiane Mattar, Silvia Daher. Maternal obesity and inflammatory mediators: A controversial associationAmerican Journal of Reproductive Immunology 2017; 77(5): e12674 doi: 10.1111/aji.12674
21
Hideki Fujita, Tadashi Terui, Koremasa Hayama, Masashi Akiyama, Shigaku Ikeda, Tomotaka Mabuchi, Akira Ozawa, Takuro Kanekura, Michiko Kurosawa, Mayumi Komine, Kimiko Nakajima, Shigetoshi Sano, Osamu Nemoto, Masahiko Muto, Yasutomo Imai, Kiyofumi Yamanishi, Yumi Aoyama, Keiji Iwatsuki. Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPPThe Journal of Dermatology 2018; 45(11): 1235 doi: 10.1111/1346-8138.14523
22
Eric M. George. New Approaches for Managing Preeclampsia: Clues From Clinical and Basic ResearchClinical Therapeutics 2014; 36(12): 1873 doi: 10.1016/j.clinthera.2014.09.023
23
Vedat Goral, Belkis Unsal, Oya Nermin Sivrikoz. A Case of Breast Cancer Following Infliximab Treatment for Treatment-Refractory Crohn’s DiseaseEuroasian Journal of Hepato-Gastroenterology 2014; 4(2): 104 doi: 10.5005/jp-journals-10018-1112
24
Corinna Weber-Schoendorfer, Marc Oppermann, Evelin Wacker, Nathalie Bernard, Delphine Beghin, Benedikte Cuppers-Maarschalkerweerd, Jonathan L. Richardson, Laura E. Rothuizen, Alessandra Pistelli, Heli Malm, Georgios Eleftheriou, Debra Kennedy, Mine Kadioglu Duman, Reinhard Meister, Christof Schaefer. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort studyBritish Journal of Clinical Pharmacology 2015; 80(4): 727 doi: 10.1111/bcp.12642
25
Jamile R. Silva, Lício F.A.A. Ferreira, Percíllia V.S. Oliveira, Ivanéia V. Nunes, Ítalo S. Pereira, Jorge Timenetsky, Lucas M. Marques, Tiana B. Figueiredo, Robson A.A. Silva. Intra-uterine experimental infection by Ureaplasma diversum induces TNF-α mediated womb inflammation in miceAnais da Academia Brasileira de Ciências 2016; 88(suppl 1): 643 doi: 10.1590/0001-3765201620150244
26
Bengt Källén. Maternal Drug Use and Infant Congenital Malformations2019; : 203 doi: 10.1007/978-3-030-17898-7_18
27
Gökçe Işıl Kurmuş, Erol Koç. Different Aspects of Behçet's Disease2020;  doi: 10.5772/intechopen.88307
28
Geoffrey C. Nguyen, Cynthia H. Seow, Cynthia Maxwell, Vivian Huang, Yvette Leung, Jennifer Jones, Grigorios I. Leontiadis, Frances Tse, Uma Mahadevan, C. Janneke van der Woude, Alain Bitton, Brian Bressler, Sharyle Fowler, John K. Marshall, Carrie Palatnick, Anna Pupco, Joel Ray, Laura Targownik, Janneke van der Woude, William Paterson. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in PregnancyGastroenterology 2016; 150(3): 734 doi: 10.1053/j.gastro.2015.12.003
29
Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda. Clinical Practice Guidelines for the Management of Pregnancy in Women With Autoimmune Rheumatic Diseases of the Mexican College of Rheumatology. Part IIReumatología Clínica (English Edition) 2015; 11(5): 305 doi: 10.1016/j.reumae.2015.03.005
30
Robyn Laube, Sudarshan Paramsothy, Rupert W Leong. Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitisExpert Opinion on Drug Safety 2021; 20(3): 275 doi: 10.1080/14740338.2021.1873948
31
Jeff Chang, Rupert WL Leong. Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposureExpert Opinion on Biological Therapy 2014; 14(1): 27 doi: 10.1517/14712598.2014.853738
32
F. Maccari, A.‐C. Fougerousse, E. Esteve, L. Frumholtz, J. Parier, C. Hurabielle, C. Cassius, C. Taieb. Crossed looks on the dermatologist's position and the patient's preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN‐PSO studyJournal of the European Academy of Dermatology and Venereology 2019; 33(5): 880 doi: 10.1111/jdv.15423
33
Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte IIReumatología Clínica 2015; 11(5): 305 doi: 10.1016/j.reuma.2014.12.004
34
Frauke Förger, Astrid Zbinden, Peter M. Villiger. Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patientsJoint Bone Spine 2016; 83(3): 341 doi: 10.1016/j.jbspin.2015.07.004
35
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part)Revista de Gastroenterología de México (English Edition) 2017; 82(2): 134 doi: 10.1016/j.rgmxen.2016.07.004
36
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte)Revista de Gastroenterología de México 2017; 82(2): 134 doi: 10.1016/j.rgmx.2016.07.005
37
Megan E.B. Clowse, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper, Uma Mahadevan. Pregnancy Outcomes in Subjects Exposed to Certolizumab PegolThe Journal of Rheumatology 2015; 42(12): 2270 doi: 10.3899/jrheum.140189
38
P A Shesternya, M M Petrova, A O Vasilyeva. New horizons in the use of biological agents during pregnancy in patients with rheumatic diseaseTerapevticheskii arkhiv 2017; 89(5): 105 doi: 10.17116/terarkh2017895105-112
39
Arsène Mekinian, Jonathan Cohen, Jaume Alijotas-Reig, Lionel Carbillon, Pascale Nicaise-Roland, Gilles Kayem, Emile Daraï, Olivier Fain, Marie Bornes. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?American Journal of Reproductive Immunology 2016; 76(1): 8 doi: 10.1111/aji.12493
40
Ariela Hoxha, Antonia Calligaro, Emma Di Poi, Susanna Peccatori, Maria Favaro, Teresa Del Ross, Roberta Ramonda, Chiara Grava, Bernd Raffeiner, Paola Ravagni, Salvatore De Vita, Amelia Ruffatti. Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre studyJoint Bone Spine 2017; 84(2): 169 doi: 10.1016/j.jbspin.2016.03.014
41
Bram P. Wispelwey, Eyal Sheiner. Inflammatory bowel disease and preterm deliveryArchives of Gynecology and Obstetrics 2013; 288(4): 725 doi: 10.1007/s00404-013-2989-3
42
Kristel K Leung, Parul Tandon, Vivek Govardhanam, Cynthia Maxwell, Vivian Huang. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysisInflammatory Bowel Diseases 2021; 27(4): 550 doi: 10.1093/ibd/izaa122
43
Michiel F. Schreuder, Huib de Jong, Ellen C. van der Kuur, Elisabeth A.M. Cornelissen. Transient generalized proximal tubular dysfunction in an infant with a urinary tract infection: the effect of maternal infliximab therapy?Case Reports in Perinatal Medicine 2021; 10(1) doi: 10.1515/crpm-2020-0050
44
Nicole W. Tsao, Larry D. Lynd, Mohsen Sadatsafavi, Gillian Hanley, Mary A. De Vera. Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population-Based Cohort StudyArthritis Care & Research 2018; 70(7): 979 doi: 10.1002/acr.23434
45
Konstantinos Papamichael, Gerassimos J. Mantzaris, Laurent Peyrin-Biroulet. A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn’s diseaseExpert Opinion on Drug Safety 2016; 15(4): 493 doi: 10.1517/14740338.2016.1145653
46
Frauke Förger, Astrid Zbinden, Peter M. Villiger. Traitement par certolizumab en fin de grossesse chez les patientes atteintes de maladies rhumatismales : faibles concentrations du médicament dans le sang du cordon ombilical mais risques possibles d’infections maternelles. Une série de 13 casRevue du Rhumatisme 2016; 83(3): 226 doi: 10.1016/j.rhum.2016.02.011
47
Anita Afzali. Inflammatory bowel disease during pregnancyCurrent Opinion in Gastroenterology 2019; 35(4): 281 doi: 10.1097/MOG.0000000000000541
48
Uma Mahadevan, Millie D. Long, Sunanda V. Kane, Abhik Roy, Marla C. Dubinsky, Bruce E. Sands, Russell D. Cohen, Christina D. Chambers, William J. Sandborn. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel DiseaseGastroenterology 2021; 160(4): 1131 doi: 10.1053/j.gastro.2020.11.038
49
Oier Ateka-Barrutia, Catherine Nelson-Piercy. Connective tissue disease in pregnancyClinical Medicine 2013; 13(6): 580 doi: 10.7861/clinmedicine.13-6-580
50
A. Mekinian, J. Cohen, G. Kayem, L. Carbillon, P. Nicaise-Roland, B. Gaugler, E. Darai, M. Bornes, O. Fain. Fausses couches précoces récurrentes inexpliquées : quelle est la place de l’immunomodulation ?La Revue de Médecine Interne 2017; 38(4): 264 doi: 10.1016/j.revmed.2016.08.001
51
Lindsay Lally, Robert F. Spiera. Contraception and Pregnancy in Patients with Rheumatic Disease2014; : 171 doi: 10.1007/978-1-4939-0673-4_9
52
Current Therapeutic Options in the Treatment of Rheumatoid ArthritisJournal of Clinical Medicine 2019; 8(7): 938 doi: 10.3390/jcm8070938
53
Kara M. De Felice, Sunanda Kane. Safety of anti-TNF agents in pregnancyJournal of Allergy and Clinical Immunology 2021; 148(3): 661 doi: 10.1016/j.jaci.2021.07.005
54
Gabriella Bröms, Fredrik Granath, Anders Ekbom, Karin Hellgren, Lars Pedersen, Henrik T. Sørensen, Olof Stephansson, Helle Kieler. Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During PregnancyClinical Gastroenterology and Hepatology 2016; 14(2): 234 doi: 10.1016/j.cgh.2015.08.039
55
Benjamin Hassid, Uma Mahadevan. The use of biologic therapy in pregnancyCurrent Opinion in Rheumatology 2014; 26(3): 347 doi: 10.1097/BOR.0000000000000048
56
K. L. Hyrich, S. M. M. Verstappen. Biologic therapies and pregnancy: the story so farRheumatology 2014; 53(8): 1377 doi: 10.1093/rheumatology/ket409
57
Gene-Siew Ngian, Andrew M. Briggs, Ilana N. Ackerman, Sharon Van Doornum. Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactationInternational Journal of Rheumatic Diseases 2016; 19(9): 834 doi: 10.1111/1756-185X.12860
58
Vivian Wai-Mei Huang, Hsiu-Ju Chang, Karen Ivy Kroeker, Karen Jean Goodman, Kathleen M. Hegadoren, Levinus Albert Dieleman, Richard Neil Fedorak. Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further EducationCanadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/6193275
59
Megan L. Krause, Shreyasee Amin, Ashima Makol. Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to knowTherapeutic Advances in Musculoskeletal Disease 2014; 6(5): 169 doi: 10.1177/1759720X14551568
60
K. Vigl, C. Posch, L. Richter, B. Monshi, K. Rappersberger. Pyoderma gangrenosum during pregnancy - treatment options revisitedJournal of the European Academy of Dermatology and Venereology 2016; 30(11): 1981 doi: 10.1111/jdv.13792
61
Martin Bortlik, Dana Duricova, Nadezda Machkova, Jana Kozeluhova, Pavel Kohout, Ludek Hrdlicka, Marianna Durilova, Katarina Mitrova, Ondrej Hradsky, Jiri Bronsky, Karin Malickova, Milan Lukas. Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed ChildrenInflammatory Bowel Diseases 2014; 20(3): 495 doi: 10.1097/01.MIB.0000440984.86659.4f
62
Yan Sun, Wensheng Pan, Jun Zhang, Ying Cui, Huiju Wang, Guoqing Ru, Legao Chen. Complex TNF-α B cell epitope MAP vaccine alleviates murine ulcerative colitisInternational Journal of Molecular Medicine 2019;  doi: 10.3892/ijmm.2019.4271
63
Wendy Marder, Emily A. Littlejohn, Emily C. Somers. Pregnancy and autoimmune connective tissue diseasesBest Practice & Research Clinical Rheumatology 2016; 30(1): 63 doi: 10.1016/j.berh.2016.05.002
64
Jantien W. Wieringa, Gertjan J. Driessen, C. Janneke Van Der Woude. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune systemExpert Review of Gastroenterology & Hepatology 2018; 12(8): 811 doi: 10.1080/17474124.2018.1496820
65
Miguel A. Saavedra, Roxana Romo-Rodríguez, Sergio R. Gutiérrez-Ureña, Dafhne Miranda-Hernández, Lilia I. Hernández-Cruz, Luis J. Jara. Targeted drugs in spondyloarthritis during pregnancy and lactationPharmacological Research 2018; 136: 21 doi: 10.1016/j.phrs.2018.08.009
66
Keita Fujikawa, Yushiro Endo, Akinari Mizokami, Kosuke Takahashi, Maiko Tabuchi, Kazuo Ohba, Hideki Nakamura, Atsushi Kawakami. Successful Treatment with Adalimumab for Intestinal Behcet's Disease during PregnancyInternal Medicine 2016; 55(10): 1375 doi: 10.2169/internalmedicine.55.6590
67
Sara Horst, Sunanda Kane. The Use of Biologic Agents in Pregnancy and BreastfeedingGastroenterology Clinics of North America 2014; 43(3): 495 doi: 10.1016/j.gtc.2014.05.005
68
C Janneke van der Woude, Herold J Metselaar, Silvio Danese. Management of gastrointestinal and liver diseases during pregnancyGut 2014; 63(6): 1014 doi: 10.1136/gutjnl-2013-305418
69
Monica Kumar, Laura Ray, Sudha Vemuri, Teresa A. Simon. Pregnancy outcomes following exposure to abatacept during pregnancySeminars in Arthritis and Rheumatism 2015; 45(3): 351 doi: 10.1016/j.semarthrit.2015.06.016
70
I. Belinchón, M. Velasco, M. Ara-Martín, S. Armesto Alonso, O. Baniandrés Rodríguez, L. Ferrándiz Pulido, M. García-Bustinduy, J.A. Martínez-López, N. Martínez Sánchez, A. Pérez Ferriols, E. Pérez Pascual, R. Rivera Díaz, R. Ruiz-Villaverde, R. Taberner Ferrer, A. Vicente Villa, J.M. Carrascosa. Consenso sobre las actuaciones a seguir durante la edad fértil, el embarazo, el posparto y la lactancia en pacientes con psoriasisActas Dermo-Sifiliográficas 2021; 112(3): 225 doi: 10.1016/j.ad.2020.10.002
71
Thomas Billiet, Paul Rutgeerts, Marc Ferrante, Gert Van Assche, Séverine Vermeire. Targeting TNF-α for the treatment of inflammatory bowel diseaseExpert Opinion on Biological Therapy 2014; 14(1): 75 doi: 10.1517/14712598.2014.858695
72
N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur, H. J. M. J. Crijns. Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic ReviewDrugs 2020; 80(16): 1699 doi: 10.1007/s40265-020-01376-y